150 related articles for article (PubMed ID: 29030227)
21. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
[TBL] [Abstract][Full Text] [Related]
22. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial.
Creinin MD; Schreiber CA; Bednarek P; Lintu H; Wagner MS; Meyn LA;
Obstet Gynecol; 2007 Apr; 109(4):885-94. PubMed ID: 17400850
[TBL] [Abstract][Full Text] [Related]
23. Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion.
Bracken H; Ngoc NT; Schaff E; Coyaji K; Ambardekar S; Westheimer E; Winikoff B
Obstet Gynecol; 2007 Apr; 109(4):895-901. PubMed ID: 17400851
[TBL] [Abstract][Full Text] [Related]
24. Medical management of missed abortion and anembryonic pregnancy.
el-Refaey H; Hinshaw K; Henshaw R; Smith N; Templeton A
BMJ; 1992 Dec; 305(6866):1399. PubMed ID: 1486304
[TBL] [Abstract][Full Text] [Related]
25. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
[TBL] [Abstract][Full Text] [Related]
26. Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
Johnson DM; Ramaswamy S; Gomperts R
Contraception; 2024 Mar; 131():110345. PubMed ID: 38049047
[TBL] [Abstract][Full Text] [Related]
27. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
[TBL] [Abstract][Full Text] [Related]
28. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
Bracken H; Dabash R; Tsertsvadze G; Posohova S; Shah M; Hajri S; Mundle S; Chelli H; Zeramdini D; Tsereteli T; Platais I; Winikoff B
Contraception; 2014 Mar; 89(3):181-6. PubMed ID: 24332431
[TBL] [Abstract][Full Text] [Related]
29. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
30. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.
Raymond EG; Shannon C; Weaver MA; Winikoff B
Contraception; 2013 Jan; 87(1):26-37. PubMed ID: 22898359
[TBL] [Abstract][Full Text] [Related]
31. [Mifepristone and misoprostol in therapeutic abortions].
Jannet D; Aflak N; Chemla JP; Marpeau L; Milliez J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):277-82. PubMed ID: 8767226
[TBL] [Abstract][Full Text] [Related]
32. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
el-Refaey H; Hinshaw K; Templeton A
Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
[TBL] [Abstract][Full Text] [Related]
33. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
[TBL] [Abstract][Full Text] [Related]
34. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review.
Chen MJ; Creinin MD
Obstet Gynecol; 2015 Jul; 126(1):12-21. PubMed ID: 26241251
[TBL] [Abstract][Full Text] [Related]
35. Concurrent use of mifepristone and misoprostol for early medical abortion.
Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
[TBL] [Abstract][Full Text] [Related]
36. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol.
Reeves MF; Monmaney JA; Creinin MD
Contraception; 2016 Feb; 93(2):119-25. PubMed ID: 26285178
[TBL] [Abstract][Full Text] [Related]
37. The mifepristone-misoprostol regimen for early medical abortion.
Ellertson C; Waldman SN
Curr Womens Health Rep; 2001 Dec; 1(3):184-90. PubMed ID: 12112968
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
[TBL] [Abstract][Full Text] [Related]
39. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
Chai J; Ho PC
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
[TBL] [Abstract][Full Text] [Related]
40. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore.
Tan YL; Singh K; Tan KH; Gosavi A; Koh D; Abbas D; Winikoff B
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():144-147. PubMed ID: 30179732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
